-

AIS Healthcare Dispensed One Millionth Prescription in 2023

DALLAS--(BUSINESS WIRE)--As 2023 draws to a close, AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to announce that it reached the milestone of dispensing one million prescriptions to patients living with chronic pain and other complex health conditions earlier this year. Since its inception more than 10 years ago, AIS Healthcare has been putting quality and safety first in the preparation and delivery of patient-specific prescriptions across the country.

At AIS Healthcare’s two 503A specialty compounding pharmacies, best-in-class licensed pharmacists go beyond state and industry standards to produce medications of the highest quality and sterility. Both facilities invest significant resources in people and processes to be able to produce prescriptions that exceed standards and expectations, using a proven, proprietary process that combines aseptic processing with terminal sterilization—a pharmaceutical industry standard—for patient-specific formulary prescriptions to achieve unprecedented sterility assurance and extended Beyond-Use Date (BUD). This gives providers confidence in the medications they prescribe and helps to reduce medication waste.

“AIS is proud to administer life-changing medications across the United States that improve patients’ quality of life. The achievement of dispensing one million prescriptions is a significant milestone. We remain committed to prioritizing patient safety in every aspect—from person to process to protocol. Our dedication to maintaining the highest standards of quality in healthcare is unwavering. We look forward to continuing the work of advancing quality and enabling patients to live better lives,” said Simon Castellanos, AIS Healthcare CEO.

About AIS Healthcare

Advancing quality. Improving lives.

As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.

Learn more at aiscaregroup.com

Contacts

Simon Castellanos
877.443.4006

AIS Healthcare


Release Versions

Contacts

Simon Castellanos
877.443.4006

More News From AIS Healthcare

AIC Opens New Infusion Care Center in Louisville, KY, Deepening Commitment to Patient Care

DALLAS--(BUSINESS WIRE)--Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of personalized infusion therapy, is pleased to announce the opening of a new Advanced Infusion Care Center (AICC). Located in Louisville, KY, this new center marks another milestone in AIC’s continued expansion and reinforces its commitment to improving access to high-quality, patient-centered infusion care nationwide. The continued growth of AICC locations reflects AIC’s focused investme...

AIS Healthcare Announces New Chief Legal & Compliance Officer

DALLAS--(BUSINESS WIRE)--AIS Healthcare, the leading provider of targeted drug delivery and infusion care solutions, is announcing the appointment of Sybil Rajan as Chief Legal Officer and Chief Compliance Officer. In this role, Sybil will lead AIS Healthcare’s Legal and Compliance departments, building upon an already strong foundation to support safe, strategic growth in an increasingly complex regulatory environment. “We are so thrilled to welcome Sybil,” said Simon Castellanos, AIS Healthca...

Atlanta, GA Is the Newest AIC Infusion Center Location, Expanding Its National Presence

DALLAS--(BUSINESS WIRE)--Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of personalized infusion therapy, is proud to announce the latest opening of an Advanced Infusion Care Center (AICC). This new location in Atlanta, GA is the latest example of AIC’s ongoing growth and commitment to helping people access compassionate, high-quality infusion services across the country. Establishing additional infusion center sites reinforces AIC’s strategic dedication to ad...
Back to Newsroom